Technology
Health
Medical

Itamar Medica

$10.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours

Why Robinhood?

You can buy or sell Itamar Medica and other stocks, options, ETFs, and crypto commission-free!

About ITMR

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. Read More The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.

Employees
Headquarters
Caesarea, Haifa
Founded
1997
Market Cap
112.89M
Price-Earnings Ratio
Dividend Yield
Average Volume
54.30
High Today
Low Today
Open Price
Volume
0.00
52 Week High
$14.00
52 Week Low
$8.27

Collections

Technology
Health
Medical
Advertising and Marketing
Rental and Lease
Medical Devices
Business Services
Finance

ITMR Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.13 per share
Actual
Available Aug 14, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.